Term ends Apr 6, 2030 · High confidence
20-year base term ends Apr 6, 2030
Apr 6, 2010
Apr 6, 2030
May 26, 2015
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 6, 2010, when applications 12/755,106, 12/755,116 and 12/755,122, the earliest non-provisional applications in its chain, were filed (this one was filed Nov 14, 2013) | Apr 6, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,324,180, US 8,329,665, US 8,329,666, US 8,609,631) | resolves to Apr 6, 2030, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 6, 2030 | High confidence |
This family
| US 6,613,753 | Term ended Mar 2021 | Mar 2021 |
| US 8,324,180 | In force Jul 2030 | Jul 2030 |
| US 8,329,665 | In force Jul 2030 | Jul 2030 |
| US 8,329,666 | In force Jul 2030 | Jul 2030 |
| US 8,609,631 | In force Apr 2030 | Apr 2030 |
| US 9,040,501 | this patent Apr 2030 | Apr 2030 |
| Application PCT/US2014/062874 | PCT application no patent term | no patent term |
| US 9,834,576 | In force Oct 2034 | Oct 2034 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 19, 2013 Reel 31626, frame 494 | Belyakov, Sergei; Duvall, Bridget; Ferraris, Dana; Hamilton, Gregory; Vaal, Mark | Eisai Inc. | Assignment of Assignor's Interest |
| May 22, 2014 Reel 32945, frame 934 | Eisai Inc. | Otsuka Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
| Jun 5, 2014 Reel 33086, frame 355 | Eisai Inc. | Otsuka Pharmaceutical Co., Ltd. | Corrective Assignment to Correct the Supporting Legal Documentation Previously Recorded on Reel 032945 Frame 0934. Assignor(S) Hereby Confirms the Addition of Missing Pages Identifying the Properties Assigned. |
| Sep 23, 2014 Reel 33794, frame 804 | Eisai Inc. | Otsuka Pharmaceutical Co., Ltd. | Assignee Change of Address |
| Aug 6, 2015 Reel 36335, frame 153 | Otsuka Pharmaceutical Co., Ltd. | Otsuka Pharmaceutical Co., Ltd. | Corrective Assignment to Correct the Address of the Assignee Previously Recorded at Reel: 033794 Frame: 0804. Assignor(S) Hereby Confirms the Assignment. |
| Dec 4, 2025 Reel 73115, frame 640 | Otsuka Pharmaceutical Co., Ltd. | Taiho Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,324,180, US 8,329,665, US 8,329,666, US 8,609,631, ends no earlier than this term, so it caps nothing.